The Evidence For Using Conjugate Vaccines To Protect HIV-Infected Children Against Pneumococcal Disease

Simple item page
dc.contributor.authorBliss, Sandra J.
dc.contributor.authorO’Brien, Katherine L.
dc.contributor.authorJanoff, Edward N.
dc.contributor.authorCotton, Mark F.
dc.contributor.authorMusoke, Philippa
dc.contributor.authorCoovadia, Hoosen
dc.contributor.authorLevine, Orin S.
dc.date.accessioned2022-01-29T13:19:29Z
dc.date.available2022-01-29T13:19:29Z
dc.date.issued2008
dc.description.abstractPneumococcal conjugate vaccines (PCVs) are a potentially useful complement to existing treatment strategies in HIV-infected children, for whom pneumococcal infections are common and serious. This Review summarises available data on the burden of pneumococcal disease and the safety and efficacy of PCVs in HIV-infected children. The data demonstrate that children with HIV have significantly increased risk of pneumococcal disease compared with uninfected children; the serotypes included in currently licensed or near-licensure conjugate vaccines include most serotypes that cause invasive pneumococcal disease (IPD) in HIV-infected children and adults; PCVs provide substantial protection against IPD and clinical pneumonia when given to HIV-infected infants; and HIV-infected adults gain an indirect benefit when children in the community are vaccinated. PCV should be considered as an important intervention for improving the lives of HIV-infected children.en_US
dc.identifier.citationBliss, S. J., O'Brien, K. L., Janoff, E. N., Cotton, M. F., Musoke, P., Coovadia, H., & Levine, O. S. (2008). The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease. The Lancet infectious diseases, 8(1), 67-80.https://doi.org/10.1016/S1473-3099(07)70242-6en_US
dc.identifier.issn1473-3099
dc.identifier.urihttps://nru.uncst.go.ug/xmlui/handle/123456789/1614
dc.language.isoenen_US
dc.publisherThe Lancet infectious diseasesen_US
dc.titleThe Evidence For Using Conjugate Vaccines To Protect HIV-Infected Children Against Pneumococcal Diseaseen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
The Evidence For Using Conjugate Vaccines To Protect.pdf
Size:
167.75 KB
Format:
Adobe Portable Document Format
Description:
The Evidence For Using Conjugate Vaccines To Protect HIV-Infected Children Against Pneumococcal Disease
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Medical and Health Sciences